WO2008155999A1 - Gaba作動性ニューロン賦活剤 - Google Patents
Gaba作動性ニューロン賦活剤 Download PDFInfo
- Publication number
- WO2008155999A1 WO2008155999A1 PCT/JP2008/060478 JP2008060478W WO2008155999A1 WO 2008155999 A1 WO2008155999 A1 WO 2008155999A1 JP 2008060478 W JP2008060478 W JP 2008060478W WO 2008155999 A1 WO2008155999 A1 WO 2008155999A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gabaergic neuron
- activator
- gabaergic
- neuron activator
- food
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- Alternative & Traditional Medicine (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- Medical Informatics (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
Abstract
安全性に優れ、かつ、GABA作動性ニューロンを賦活し得るGABA作動性ニューロン賦活剤を提供する。 本発明のGABA作動性ニューロン賦活剤は、醗酵人参エキスを有効成分として含有する。本発明の睡眠障害の予防または治療のために用いられる旨の表示を付した飲食物は、該GABA作動性ニューロン賦活剤を含有し、GABA作動性ニューロン賦活作用を有することを特徴とする。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009520424A JP5204771B2 (ja) | 2007-06-21 | 2008-06-06 | Gaba作動性ニューロン賦活剤 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007164115 | 2007-06-21 | ||
JP2007-164115 | 2007-06-21 | ||
JP2007-196222 | 2007-07-27 | ||
JP2007196222 | 2007-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008155999A1 true WO2008155999A1 (ja) | 2008-12-24 |
Family
ID=40156158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/060478 WO2008155999A1 (ja) | 2007-06-21 | 2008-06-06 | Gaba作動性ニューロン賦活剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5204771B2 (ja) |
WO (1) | WO2008155999A1 (ja) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012527233A (ja) * | 2009-05-19 | 2012-11-08 | イル・ファ・カンパニー・リミテッド | 発酵高麗人参濃縮液または粉末の製造方法 |
CN103169787A (zh) * | 2012-11-30 | 2013-06-26 | 云南白药天颐茶品有限公司 | 一种具有提高睡眠质量延长深度睡眠时间的组合物及其应用 |
JP2013529899A (ja) * | 2010-05-14 | 2013-07-25 | 株式会社ジーシーエイチアンドピー | ジンセノサイド成分を増加させた新規な加工人参または加工人参抽出物の製造方法 |
JP2015168614A (ja) * | 2014-03-04 | 2015-09-28 | 長瀬産業株式会社 | Glp−1分泌促進剤 |
KR20160130779A (ko) | 2014-03-25 | 2016-11-14 | 가부시키가이샤 야쿠르트 혼샤 | 수면의 질 개선제 |
WO2017047777A1 (ja) * | 2015-09-18 | 2017-03-23 | 国立大学法人徳島大学 | ストレス負荷解放後のセロトニン欠乏改善剤 |
WO2017047776A1 (ja) * | 2015-09-18 | 2017-03-23 | 国立大学法人徳島大学 | 血中トリプトファン濃度上昇抑制剤 |
CN107375374A (zh) * | 2017-08-21 | 2017-11-24 | 东方红(通化)生物医药股份有限公司 | 一种具有辅助改善睡眠作用的西洋参/人参提取物的发酵提取方法 |
JP2017222601A (ja) * | 2016-06-15 | 2017-12-21 | 国立大学法人広島大学 | 神経変性疾患治療剤 |
CN108042592A (zh) * | 2018-02-09 | 2018-05-18 | 云南三七科技有限公司 | 一种熟三七饮片的制备方法 |
WO2018123910A1 (ja) * | 2016-12-28 | 2018-07-05 | 小林製薬株式会社 | 男性ホルモン増加促進用組成物 |
CN109715177A (zh) * | 2016-03-14 | 2019-05-03 | 赫罗微生物群公司 | 调节消化道微生物组以治疗精神病或中枢神经系统疾病 |
US10709749B2 (en) | 2013-08-30 | 2020-07-14 | Green Cross Wellbeing Corporation | Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6450878B1 (ja) * | 2018-03-28 | 2019-01-09 | 株式会社ナガセビューティケァ | 発酵物の製造方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09176017A (ja) * | 1995-12-27 | 1997-07-08 | Happy World:Kk | 制癌剤 |
JPH10212296A (ja) * | 1997-01-29 | 1998-08-11 | Happy World:Kk | 糖尿病に伴う腎疾患治療剤 |
JP2004049154A (ja) * | 2002-07-23 | 2004-02-19 | Hideo Hasegawa | サポニン分解物を含む発酵人参およびその製造方法 |
CN1895256A (zh) * | 2006-06-09 | 2007-01-17 | 上海中药创新研究中心 | 20(s)-原人参二醇在制备抗抑郁药物中的应用 |
CN1931177A (zh) * | 2006-09-21 | 2007-03-21 | 上海中药创新研究中心 | 20(s)-原人参二醇衍生物在制备抗抑郁药物中的应用 |
KR20070052256A (ko) * | 2007-05-03 | 2007-05-21 | 홍림통산(주) | 유산균으로 감마-아미노부틸산과 생물전환 사포닌을 동시에강화한 발효 인삼 조성물 |
-
2008
- 2008-06-06 WO PCT/JP2008/060478 patent/WO2008155999A1/ja active Application Filing
- 2008-06-06 JP JP2009520424A patent/JP5204771B2/ja active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09176017A (ja) * | 1995-12-27 | 1997-07-08 | Happy World:Kk | 制癌剤 |
JPH10212296A (ja) * | 1997-01-29 | 1998-08-11 | Happy World:Kk | 糖尿病に伴う腎疾患治療剤 |
JP2004049154A (ja) * | 2002-07-23 | 2004-02-19 | Hideo Hasegawa | サポニン分解物を含む発酵人参およびその製造方法 |
CN1895256A (zh) * | 2006-06-09 | 2007-01-17 | 上海中药创新研究中心 | 20(s)-原人参二醇在制备抗抑郁药物中的应用 |
CN1931177A (zh) * | 2006-09-21 | 2007-03-21 | 上海中药创新研究中心 | 20(s)-原人参二醇衍生物在制备抗抑郁药物中的应用 |
KR20070052256A (ko) * | 2007-05-03 | 2007-05-21 | 홍림통산(주) | 유산균으로 감마-아미노부틸산과 생물전환 사포닌을 동시에강화한 발효 인삼 조성물 |
Non-Patent Citations (3)
Title |
---|
HASEGAWA H.: "Probiotics no Kino to Sayo Kanpo to Probiotics", SHUKAN IGAKU NO AYUMI, vol. 207, no. 10, 2003, pages 857 - 861 * |
KIMURA T. ET AL.: "Interactions of Ginsenosides with Ligand-bindings of GABAA and GABAB Receptors", GEN. PHARMACOL., vol. 25, no. 1, 1994, pages 193 - 199, XP023803990 * |
TACHIKAWA E. ET AL.: "Effects of ginseng saponins on responses induced by various receptor stimuli", EUR. J. PHARMACOL., vol. 369, no. 1, 1999, pages 23 - 32 * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012527233A (ja) * | 2009-05-19 | 2012-11-08 | イル・ファ・カンパニー・リミテッド | 発酵高麗人参濃縮液または粉末の製造方法 |
US9512453B2 (en) | 2010-05-14 | 2016-12-06 | Green Cross Wellbeing Corporation | Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased |
JP2013529899A (ja) * | 2010-05-14 | 2013-07-25 | 株式会社ジーシーエイチアンドピー | ジンセノサイド成分を増加させた新規な加工人参または加工人参抽出物の製造方法 |
CN103169787B (zh) * | 2012-11-30 | 2014-11-26 | 云南白药天颐茶品有限公司 | 一种具有提高睡眠质量延长深度睡眠时间的组合物及其应用 |
CN103169787A (zh) * | 2012-11-30 | 2013-06-26 | 云南白药天颐茶品有限公司 | 一种具有提高睡眠质量延长深度睡眠时间的组合物及其应用 |
US11464821B2 (en) | 2013-08-30 | 2022-10-11 | Green Cross Wellbeing Corporation | Composition for reducing cancer cachexia or weight loss caused by anticancer drug therapy or radiation therapy comprising ginseng extract having increased ginsenoside Rg3 and Rh2 |
US10709749B2 (en) | 2013-08-30 | 2020-07-14 | Green Cross Wellbeing Corporation | Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent |
JP2015168614A (ja) * | 2014-03-04 | 2015-09-28 | 長瀬産業株式会社 | Glp−1分泌促進剤 |
KR20160130779A (ko) | 2014-03-25 | 2016-11-14 | 가부시키가이샤 야쿠르트 혼샤 | 수면의 질 개선제 |
US11331353B2 (en) | 2014-03-25 | 2022-05-17 | Kabushiki Kaisha Yakult Honsha | Sleep quality improver |
JPWO2017047776A1 (ja) * | 2015-09-18 | 2018-07-12 | 国立大学法人徳島大学 | 血中トリプトファン濃度上昇抑制剤 |
WO2017047777A1 (ja) * | 2015-09-18 | 2017-03-23 | 国立大学法人徳島大学 | ストレス負荷解放後のセロトニン欠乏改善剤 |
WO2017047776A1 (ja) * | 2015-09-18 | 2017-03-23 | 国立大学法人徳島大学 | 血中トリプトファン濃度上昇抑制剤 |
JPWO2017047777A1 (ja) * | 2015-09-18 | 2018-07-12 | 国立大学法人徳島大学 | ストレス負荷解放後のセロトニン欠乏改善剤 |
CN109715177A (zh) * | 2016-03-14 | 2019-05-03 | 赫罗微生物群公司 | 调节消化道微生物组以治疗精神病或中枢神经系统疾病 |
JP2017222601A (ja) * | 2016-06-15 | 2017-12-21 | 国立大学法人広島大学 | 神経変性疾患治療剤 |
WO2018123910A1 (ja) * | 2016-12-28 | 2018-07-05 | 小林製薬株式会社 | 男性ホルモン増加促進用組成物 |
US11253532B2 (en) | 2016-12-28 | 2022-02-22 | Kobayashi Pharmaceutical Co., Ltd. | Composition for promoting increase in androgen |
CN107375374A (zh) * | 2017-08-21 | 2017-11-24 | 东方红(通化)生物医药股份有限公司 | 一种具有辅助改善睡眠作用的西洋参/人参提取物的发酵提取方法 |
CN108042592A (zh) * | 2018-02-09 | 2018-05-18 | 云南三七科技有限公司 | 一种熟三七饮片的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2008155999A1 (ja) | 2010-08-26 |
JP5204771B2 (ja) | 2013-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008155999A1 (ja) | Gaba作動性ニューロン賦活剤 | |
WO2008023266A3 (en) | Kiwi extract | |
EP1767212A4 (en) | USE OF A PLANT OF THE GENUS AMPELOPSIS AND EXTRACTS OF THIS PLANT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND A FUNCTIONAL FOOD | |
WO2010002283A3 (en) | New insulin analogues of prolonged activity | |
WO2007146411A3 (en) | Nanoshell therapy | |
WO2010060937A3 (en) | Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor | |
WO2005097119A3 (en) | Pten inhibitors | |
WO2012087047A3 (en) | Percutaneous absorption preparation containing rivastigmine | |
WO2010088450A3 (en) | Arylamide derivatives useful in the treatment of diseases associated with serca activity | |
WO2006085115A3 (en) | Therapeutic uses of tomato extracts | |
WO2008155998A1 (ja) | 抗不安抗うつ剤 | |
WO2008070859A3 (en) | Treatment of skin conditions by dickkopf1 (dkk1) | |
WO2009078447A1 (ja) | 抗ノロウイルス剤、抗インフルエンザウイルス剤、およびこれらを用いた抗ウイルス処理方法 | |
WO2008096203A3 (en) | Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders | |
WO2011051633A3 (fr) | Utilisation d'un extrait de punica granatum pour lutter contre la canitie | |
WO2008085875A3 (en) | R-zileuton for use in conditions associated with increased 5-lipoxygenase and/or leukotriene activity (eg asthma) | |
WO2008120712A1 (ja) | 交感神経活動亢進作用を有する医薬組成物又は飲食物 | |
WO2011095882A8 (en) | Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency | |
AU2010283453A8 (en) | Combination of proanthocyanidins such as Pycnogenol or grape seeds and Centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis | |
WO2012000962A3 (en) | Use of chicoric acid and lactic bacterium in food supplement for regulating skin pigmentation | |
WO2007083006A3 (fr) | Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillissement cutane | |
WO2008126367A1 (ja) | 精神安定剤および機能性食品 | |
TW200637542A (en) | Lipase inhibitor, preventing and treating agent of skin disease | |
WO2011118957A3 (ko) | 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물 | |
WO2011141113A3 (de) | Kombination aus vitamin k und nikotinamid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08765291 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009520424 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08765291 Country of ref document: EP Kind code of ref document: A1 |